| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.08 |